Nicholas Augustinos
At a glance: Nicholas Augustinos is Director at Dexcom (DXCM). Their latest SEC Form 4, filed Sep 16, 2026, reported a sale of $130K. On file: 0 purchase lines ($0) and 2 sale lines ($680K).
Disclosed holdings: about $2.3M of DXCM stock: 29,293 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Sep 16, 2026), valued at the Nov 19, 2026 close of $79.36. This counts only DXCM shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Dexcom Inc (DXCM)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Nicholas Augustinos's InsiderPrint
2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (0)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 16SEC | DXCMDexcom Inc | Sell Plan | 1,55035,832 held (−4%) | $84.02 | $130K | -5.5% |
| Sep 16SEC | DXCMDexcom Inc | Sell Plan | 6,53929,293 held (−18%) | $84.04 | $550K | -5.6% |
- Sell
Director Nicholas Augustinos sold $130K of DXCM at $84.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Nicholas Augustinos sold $550K of DXCM at $84.04 — pre-scheduled 10b5-1 plan sale.
Follow Nicholas Augustinos
Get one email when Nicholas Augustinos files a new purchase or sale. Free.
At most one email a day about Nicholas Augustinos, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.